SCHEMBL23740386

SCHEMBL23740386

c1ccc(-c2nc(-c3ccc4ccccc4c3)nc(-c3cccc4oc5c(-n6c7ccc8ccccc8c7c7c8ccccc8ccc76)cccc5c34)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
TP53 P04637 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP1A2 P05177 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 3/20 0.34
AKT1 P31749 1/20 0.34
TSHR P16473 2/20 0.33
HPGD P15428 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ATM Q13315 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP1A1 P04798 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21863017 0.99 ALDH1A1 (0.33) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL23740588 0.97 AKT1 (0.33) ALDH1A1CYP1A2MAPTAKT1CYP1A1
SCHEMBL21863013 0.95 ALDH1A1 (0.32) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL21862723 0.95 ALDH1A1 (0.32) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL23740576 0.95 ALDH1A1 (0.31) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL23740510 0.94 ALDH1A1 (0.32) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL21863031 0.94 ALDH1A1 (0.32) ALDH1A1CYP1A2MAPTAKT1CYP1A1
SCHEMBL21863039 0.94 MAPT (0.36) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL21862999 0.94 MAPT (0.37) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL23740329 0.94 ALDH1A1 (0.32) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT MATERIALS CO., LTD. (KR) 2021-12-23 US disclosed
EP-3862353-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT Materials Co., Ltd. (KR) 2021-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE ODC1, AOX1, CYP1B1 ALDH1A1 15/4885KDM4E 2786/4885TP53 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.